Published: March 8th 2025 | Updated: March 12th 2025
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis
Published: March 8th 2025 | Updated: March 12th 2025
Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab
Published: March 7th 2025 | Updated: March 12th 2025
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis
Published: March 7th 2025 | Updated: March 12th 2025
Real-World Evidence Reveals Key Insights on Hidradenitis Suppurativa
Published: March 7th 2025 | Updated: March 12th 2025
Bimekizumab Demonstrates Sustained Efficacy in Moderate-to-Severe Plaque Psoriasis Over Five Years
Published: March 7th 2025 | Updated: March 12th 2025
Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp and Body Psoriasis